PUBLICATION ETHICS AND MALPRACTICE STATEMENT (PEMS)
(LAST UPDATED: 01 OCT 2018)
International Journal for Pharmaceutical Research Scholars (IJPRS) always ready to follows coming and upcoming national and international laws. The Journals strictly ready to follow publication ethics and malpractice statement (PEMS) which was guideline by Core Practices (COPE). The full detail of COPE rules can be found on https://publicationethics.org/core-practices.
We always follow complete standards of publication ethics and implement all possible actions against publication malpractices. IJPRS always ready to take a suspicious malpractices actives and assure researcher and visitor to provide a pure and unique research data which was not possible to found in any other worldwide pharmacy journals. Journal also take care of any plagiarism issue or mistaken done knowingly or unknowingly by the research authors and try to eliminate it as fast as possible.
Highlights provided by the COPE and followed by IJPRS:
Journals should have a clearly described process for handling allegations, however, they are brought to the journal’s or publisher’s attention. Journals must take seriously allegations of misconduct pre-publication and post-publication. Policies should include how to handle allegations from whistleblowers.
2. Authorship and contributorship
Clear policies (that allow for transparency around who contributed to the work and in what capacity) should be in place for requirements for authorship and contributorship as well as processes for managing potential disputes.
Journals should have a clearly described process for handling complaints against the journal, its staff, editorial board or publisher.
4. Conflicts of interest / Competing interests
There must be clear definitions of conflicts of interest and processes for handling conflicts of interest of authors, reviewers, editors, journals ..and publishers, whether identified before or after publication.
Journals should include policies on data availability and encourage the use of reporting guidelines and registration of clinical trials and other study designs according to standard practice in their discipline.
Ethical oversight should include, but is not limited to, policies on consent to publication, publication on vulnerable populations, ethical conduct of research using animals, ethical conduct of research using human subjects, handling confidential data and of business/marketing practices.
All policies on intellectual property, including copyright and publishing licenses, should be clearly described. In addition, any costs associated with publishing should be obvious to authors and readers. Policies should be clear on what counts as prepublication that will preclude consideration. What constitutes plagiarism and redundant/overlapping publication should be specified.
A well-described and implemented infrastructure is essential, including the business model, policies, processes and software for efficient running of an editorially independent journal, as well as the efficient management and training of editorial boards and editorial and publishing staff.
All peer review processes must be transparently described and well managed. Journals should provide training for editors and reviewers and have policies on diverse aspects of peer review, especially with respect to adoption of appropriate models of review and processes for handling conflicts of interest, appeals and disputes that may arise in peer review. IJPRS Peer Review process can be Check Here.
10. Post-publication discussions and corrections
Journals must allow debate post publication either on their site, through letters to the editor, or on an external moderated site, such as PubPeer. They must have mechanisms for correcting, revising or retracting articles after publication.
Ethics of Human and Animal Experimentation
The use of human or animal for the test or any kind of study must have proper approval. Article authors and coauthors which shows animal testing do have there own letter of approval from the Animal & Ethical committee. Author and coauthors are abiding to prove this approval at any time in future. The approval must be evaluated that the animal may not get an effect in depth or a minimum number of animals has been sacrificed. All clinical trials must be reigistered and well documented.
Journal strickly follows any kind of malpractice catch by the editorial board member. The board members are highly sensitive to malpractice done by any author. If even after publication any article found any mischief with proof that the article was submitted and published by using malpractice technique then it will be removed without the intimation to authors.